NASDAQ:GBT

Global Blood Therapeutics - GBT News Headlines

$66.59

-0.01 (-0.02%)

(As of 08/9/2022 12:00 AM ET)

Add

Compare

Today's Range: $66.46
▼
$66.66
50-Day Range: $22.30
▼
$66.60
52-Week Range: $21.65
▼
$73.02

Volume: 7.28 million shs
Average Volume: 1.73 million shs
Market Capitalization: $4.33 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $61.40

Get Global Blood Therapeutics News Delivered to You Automatically

GBT Media Mentions By Week

GBT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GBT
News Sentiment
▼
0.00

0.48
▲
Average
Medical
News Sentiment

GBT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GBT Articles
This Week
▼
54

3
▲
GBT Articles
Average Week

Source

Source	Headline
	SVB Leerink Lowers Global Blood Therapeutics (NASDAQ:GBT) to Market Perform marketbeat.com - August 9 at 11:12 AM
	Global Blood Therapeutics (NASDAQ:GBT) Posts Quarterly Earnings Results, Misses Expectations By $0.07 EPS marketbeat.com - August 9 at 9:17 AM
	Pfizer buying spree continues with $5.4B hematology deal marketbeat.com - August 8 at 8:41 AM
	Pfizer buying spree continues with $5.4B hematology deal marketbeat.com - August 8 at 7:51 AM
	Global Blood Therapeutics (NASDAQ:GBT) Rating Increased to Buy at Canaccord Genuity Group americanbankingnews.com - August 10 at 1:46 AM
	GLOBAL BLOOD THERAPEUTICS, INC. ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of GBT and Encourages Investors to Contact the Firm benzinga.com - August 9 at 11:19 PM
	Pfizer To Acquire Blood Disorder Drugmaker Global Blood Therapeutics For $5.4B 247wallst.com - August 9 at 1:18 PM
	Where Global Blood Therapeutics Stands With Analysts markets.businessinsider.com - August 9 at 1:18 PM
	8 Analysts Have This to Say About Global Blood Therapeutics markets.businessinsider.com - August 9 at 1:18 PM
	Global Blood (GBT) to be Acquired by Pfizer, Misses on Earnings finance.yahoo.com - August 9 at 1:18 PM

	Global Blood Therapeutics (NASDAQ:GBT) Given Neutral Rating at Wedbush americanbankingnews.com - August 9 at 8:22 AM
	Global Blood Therapeutics (NASDAQ:GBT) Lowered to "Mkt Perform" at William Blair americanbankingnews.com - August 9 at 6:14 AM
	SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Global Blood Therapeutics, Inc. (Nasdaq – GBT) apnews.com - August 9 at 3:17 AM
	Pfizer agrees to $5.4B deal for Global Blood Therapeutics msn.com - August 8 at 5:05 PM
	Pfizer To Buy Global Blood Therapeutics In $5.4 Bln All-cash Deal nasdaq.com - August 8 at 5:05 PM
	Global Blood Therapeutics Shares Tick Higher After Pfizer Buy Agreed msn.com - August 8 at 5:05 PM
	Flush with cash, Pfizer buys Global Blood Therapeutics in $5.4 bln deal reuters.com - August 8 at 5:05 PM
	Pfizer Buys Global Blood Therapeutics. How the Deal Could Solve Pipeline Worries. barrons.com - August 8 at 5:05 PM
	Pfizer Agrees to $5.4 Billion Deal for Global Blood Therapeutics finance.yahoo.com - August 8 at 5:05 PM
	Why Global Blood Therapeutics Stock Was Trouncing the Market Today finance.yahoo.com - August 8 at 5:05 PM
	Why Pfizer's $5.4 Billion GBT Takeover Is 'Mutually Beneficial' finance.yahoo.com - August 8 at 5:05 PM
	Global Blood Therapeutics (NASDAQ:GBT) Sees Large Volume Increase americanbankingnews.com - August 7 at 3:56 AM
	Biotech ETFs Rally as Global Blood Therapeutics Surges on Potential Pfizer Deal nasdaq.com - August 6 at 9:41 PM
	Global Blood Therapeutics (NASDAQ:GBT) Sets New 52-Week High at $48.00 americanbankingnews.com - August 6 at 5:32 AM
	Pfizer in advanced talks to buy Global Blood Therapeutics for $5 bln - WSJ reuters.com - August 5 at 3:45 PM
	Pfizer in Global Blood Therapeutics Takeover Talks investing.com - August 5 at 3:45 PM
	Pfizer, Global Blood Therapeutics In Advanced Talks For $5B Buyout Deal: Report finance.yahoo.com - August 5 at 3:45 PM
	Pfizer in talks to buy Global Blood Therapeutics for roughly $5bn ft.com - August 5 at 3:45 PM
	Pfizer in Advanced Talks to Buy Global Blood Therapeutics for About $5 Billion finance.yahoo.com - August 5 at 3:45 PM
	WSJ: Pfizer considering buying Global Blood Therapeutics for roughly $5 billion finance.yahoo.com - August 5 at 3:45 PM
	Pfizer in Talks to Buy Global Blood Therapeutics for $5 Billion, Report Says finance.yahoo.com - August 5 at 3:45 PM
	Pfizer in Talks to Buy Sickle-Cell Drugmaker for $5 Billion, WSJ Reports finance.yahoo.com - August 5 at 3:45 PM
	Why Global Blood Therapeutics Stock Is Vaulting Higher Today finance.yahoo.com - August 5 at 3:45 PM
	Pfizer Is Reportedly In 'Advanced Talks' To Buy Global Blood Therapeutics For $5 Billion finance.yahoo.com - August 5 at 3:45 PM

	Strength Seen in Global Blood (GBT): Can Its 41.4% Jump Turn into More Strength? finance.yahoo.com - August 5 at 10:44 AM
	Traders Buy Large Volume of Global Blood Therapeutics Call Options (NASDAQ:GBT) americanbankingnews.com - August 5 at 1:42 AM
	Why Global Blood Therapeutics Stock Is Soaring Today theglobeandmail.com - August 4 at 7:42 PM
	Pharmaceutical Giants Eye Global Blood Therapeutics Takeover - Bloomberg investing.com - August 4 at 2:42 PM
	Stock Market Lower As Crude Oil Prices Fall Below $90 finance.yahoo.com - August 4 at 2:42 PM
	Global Blood Therapeutics shares jump 34% after Bloomberg report about 'takeover interest' finance.yahoo.com - August 4 at 9:39 AM
	4GBT : Why Global Blood Therapeutics Stock Is Surging After Hours benzinga.com - August 3 at 6:35 PM
	Q3 2022 EPS Estimates for Global Blood Therapeutics, Inc. (NASDAQ:GBT) Decreased by Analyst americanbankingnews.com - July 31 at 2:04 AM
	GBT to Announce Second Quarter 2022 Financial Results on Monday, August 8, 2022 finance.yahoo.com - July 29 at 8:46 AM
	Analysts Estimate Regeneron (REGN) to Report a Decline in Earnings: What to Look Out for finance.yahoo.com - July 27 at 2:39 PM
	Earnings Preview: Global Blood Therapeutics (GBT) Q2 Earnings Expected to Decline finance.yahoo.com - July 26 at 1:11 PM
	MHRA Grants Marketing Authorization for GBT’s Oxbryta® (voxelotor) for Use in Great Britain for the Treatment of Hemolytic Anemia in Patients with Sickle Cell Disease Age 12 Years and Older finance.yahoo.com - July 26 at 8:11 AM
	Global Blood Therapeutics Inc - Stock Quote GBT morningstar.com - July 19 at 6:16 PM
	GBT Initiates Expanded Access Program for Voxelotor in Patients With Sickle Cell Disease in Brazil finance.yahoo.com - July 14 at 11:03 AM
	The GBT Foundation Awards $250,000 in ACE Grants to Support Sickle Cell Disease Community-Based Organizations finance.yahoo.com - July 13 at 9:09 AM
	Global Blood Therapeutic Stock Sees Relative Strength Rating Rise To 91 finance.yahoo.com - July 5 at 8:41 PM
	Global Blood (GBT) Initiates Phase II Study on SCD Candidate finance.yahoo.com - June 30 at 4:31 PM
	Why Global Blood Therapeutics Trended Upward Today finance.yahoo.com - June 29 at 8:29 PM
	GBT begins phase 2/3 clinical trial of GBT601 to treat sickle cell disease seekingalpha.com - June 29 at 10:27 AM
	GBT Initiates Phase 2/3 Clinical Trial of GBT601 in Patients with Sickle Cell Disease finance.yahoo.com - June 29 at 10:27 AM

Get Global Blood Therapeutics News Delivered to You Automatically

This page (NASDAQ:GBT) was last updated on 8/10/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms